Amiel Segal

RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Talia Golan, Elina Zorde Khvalevsky, Ayala Hubert et al. · Oncotarget · 2015 · 326 citations · Full text

Medicine, Oncology, Pharmacology +12

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

Maeve A. Lowery, David P. Kelsen, Marinela Capanu et al. · European Journal of Cancer · 2017 · 151 citations · Full text

Medicine, Oncology, Chemotherapy +8

Cancer patient expectations of and communication with oncologists and oncology nurses: the experience of an integrated oncology and palliative care service

Rama Sapir, Raphael Catane, Bella Kaufman et al. · Supportive Care in Cancer · 2000 · 124 citations

Medicine, Oncology, Oncology Nursing +17

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline <i>BRCA</i> mutation carriers and wild‐type <i>BRCA</i> pancreatic ductal adenocarcinoma

Eileen M. O’Reilly, Jonathan W. Lee, Maeve A. Lowery et al. · Cancer · 2018 · 103 citations

Medicine, Oncology, Pharmacology +12

Purification and Properties of the Cystathionine γ-Cleavage Enzyme of Neurospora

Martin Flavin, Amiel Segal · Journal of Biological Chemistry · 1964 · 61 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9